After confirmation via WB of the dysregulation by SPRYD7 of the indicated proteins and/or proteins interacting with SPRYD7, our results suggest a novel and interesting role of SPRYD7 in CRC progression and metastasis. Here, SPRYD7 is linked to colorectal carcinoma.